21 February 2002 Source: http://www.access.gpo.gov/su_docs/aces/fr-cont.html ------------------------------------------------------------------------- [Federal Register: February 21, 2002 (Volume 67, Number 35)] [Notices] [Page 8011] From the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr21fe02-54] ----------------------------------------------------------------------- DEPARTMENT OF DEFENSE Department of the Army Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Patent Concerning Hantavirus Vaccine AGENCY: Department of the Army, DoD. ACTION: Notice. ----------------------------------------------------------------------- SUMMARY: In accordance with 37 CFR 404.6, announcement is made of the availability for licensing of U.S. Patent No. 5,614,193 entitled ``Hantavirus Vaccine'' issued March 25, 1997. The United States government as represented by the Secretary of the Amy has rights in this invention. ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, Frederick, Maryland 21702-5012. FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul Mele, Office of Research & Technology Assessment, (301) 619-6664. Both at telefax (301) 61-5034. SUPPLEMENTARY INFORMATION: Vaccine formulations for inducing protective immune response to Hantaviruses in humans are disclosed. These formulations include an attenuated vaccine virus vector containing cDNA's encoding Hantavirus nucleocapsid N protein, G1 and G2 glycoproteins. Methods for the use of these formulations also are disclosed. Luz D. Ortiz, Army Federal Register Liaison Officer. [FR Doc. 02-4180 Filed 2-20-02; 8:45 am] BILLING CODE 3710-08-M